Home » Carbylan BioSurgery Announces Positive Clinical Trial Results for Hydros-TA in Patients with Pain from Knee Osteoarthritis
Carbylan BioSurgery Announces Positive Clinical Trial Results for Hydros-TA in Patients with Pain from Knee Osteoarthritis
Carbylan BioSurgery announced positive results in its double-blinded, multi-center clinical trial which evaluated the safety and effectiveness of Hydros-TA Joint Therapy and Hydros as compared to Synvisc-One in patients with osteoarthritis of the knee.
SYS-CON
SYS-CON
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May